ArticleCancer research2022

A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture.

Sanjiban Chakrabarty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.